Unexpected illnesses are plaguing a legendary guitarist.
When his two-disc “Frampton Comes Alive” album sold 11 million copies in the 1970s—more than any other live album at the time—Peter Frampton created rock and roll history.
The seasoned musician and singer-songwriter is currently fighting inclusion body myositis (IBM) with bravery, creating medical history in the process. This inflammatory disease is characterized by persistent, growing inflammation of the muscles, degeneration and weakness of the muscles, weariness, incapacity, and, in the early stages, lightheadedness and a predisposition to fall.
It is entirely true to state that Peter has made history in both music and medicine. “He now has two legacies,” remarked Dr. Lisa Christopher-Stine, the director of the Johns Hopkins Myositis Center in Baltimore and the rheumatologist treating Frampton.
This 2024 Rock & Roll is deeply entwined with these two legacies.
Hall of Fame nominee, both on and off stage, and with a guitar or not.
Frampton, who now performs seated rather than standing and uses a cane, stated, “Every note I play now is so much more important to me because I know one of the notes I play will be the last I play within my lifetime.” He will end his spring leg of the “Never Ever Say Never” tour on Sunday at Jacobs Park’s Rady Shell in San Diego.
Frampton went on, “I’m a very optimistic person and am dealing with what I’ve got.” “This is the direction my life has taken, and I’m fighting for a cure—what we want.”
Famous for hits like “Show Me the Way,” “Baby, I Love Your Way,” and “Do You Feel Like We Do?”, Frampton is doing more than just talking the talk when it comes to his fight against IBM, finding successful treatment options, and raising awareness of the condition among others.
He made his illness known to the public in 2019 during an interview with “CBS This Morning: Saturday.” To raise funds for research, he founded the Peter Frampton Myositis Research Fund at Johns Hopkins.
After every show on what he believed to be his final tour in 2019, Frampton set aside additional time to mfocus on a health issue that many individuals were previously unaware of.
Frampton was awarded the 2023 Patient Ambassador Award by the Myositis Association. His “extraordinary effort and success” in promoting legislative advocacy campaigns for rare diseases, such as myositis, and in generating money to support TMA and its educational purpose were recognized with this accolade.eet with fans who owned IBMs. He effectively assumed the role of IBM’s public face, utilizing his notoriety to bring
